Molecular mechanisms involved in the synergistic interaction of the EZH2 inhibitor 3-deazaneplanocin A (DZNeP) with gemcitabine in pancreatic cancer cells

Pancreatic ductal adenocarcinoma (PDAC) is characterized by overexpression of Enhancer-of Zeste-Homolog-2 (EZH2), which plays a pivotal role in cancer-stem-cell (CSC) self-renewal through methylation of histone-H3-lysine-27 (H3K27m3). Against this background, EZH2 was identified as an attractive tar...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Avan, Amir, Crea, Francesco, Paolicchi, Elisa, Funel, Niccola, Galvani, Elena, Marquez, Victor E, Honeywell, Richard J., Danesi, Romano, Peters, Godefridus J., Giovannetti, Elisa
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: 2012
Gaiak:
Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC3416916/
https://ncbi.nlm.nih.gov/pubmed/22622284
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1535-7163.MCT-12-0037
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak